about
Prescribing for patients on dialysisp-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.Dynamic Analysis of Kidney Function and Its Correlation with Nutritional Indicators in a Large Sample of Hospitalized Elderly Patients.An adsorbent monolith device to augment the removal of uraemic toxins during haemodialysis.Dialysis cannot be dosed.Warfarin dosing in patients with impaired kidney functionGut-Microbiota-Metabolite Axis in Early Renal Function Decline.Selectively increasing the clearance of protein-bound uremic solutesLC-MS/MS method for simultaneous determination of serum p-cresyl sulfate and indoxyl sulfate in patients undergoing peritoneal dialysis.Microbiota-Derived Phenylacetylglutamine Associates with Overall Mortality and Cardiovascular Disease in Patients with CKD.Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during HemodialysisMetabolism, Protein Binding, and Renal Clearance of Microbiota-Derived p-Cresol in Patients with CKD.Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD.Serum concentrations of p-cresyl sulfate and indoxyl sulfate, but not inflammatory markers, increase in incident peritoneal dialysis patients in parallel with loss of residual renal function.Stability of therapeutic albumin solutions used for molecular adsorbent recirculating system-based liver dialysis.The gut-kidney axis.Improved dialytic removal of protein-bound uraemic toxins with use of albumin binding competitors: an in vitro human whole blood studyp-Cresyl sulfate and indoxyl sulfate in pediatric patients on chronic dialysis.Guanidinylations of albumin decreased binding capacity of hydrophobic metabolites.The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
P2860
Q26752999-758B3C92-92C7-45CB-B313-29A7132C11F3Q33560454-6E6DC434-811B-4C88-AD59-9F74BDAECC2DQ33620715-503B91FB-3E1D-4A5D-A9DA-F91F7AB0CAFFQ33663437-B66D41B5-22C7-480F-8314-56DEDB4DDEFEQ34014962-7F607401-C911-4F56-BF03-B97892358901Q34238435-79B7E62B-B545-4BCF-92F0-27482C97D7C3Q35737363-67D6838E-88CE-4230-8FC1-1402560057FAQ35861459-07AA0423-9F08-413A-8CF9-FC5A2EE84609Q36003748-B22200B7-73D2-4028-9EC0-65630F769A53Q36031714-5123284D-7A48-465A-90BA-04CBE16704DCQ36226824-4AF801D2-711E-42C0-ACF3-7CA7DF4CED17Q37069948-A877AFBB-F197-439B-8C55-E69E184ABA70Q37246931-E92A8B76-E547-4B33-B68D-BCED055C31CFQ37582625-C8B57295-12D2-4496-890D-07004D77C5D1Q38461901-A58DC5B6-E965-4907-808C-94AD4BFCB47EQ39009765-CCE16F00-29DC-4A84-B6E7-F166855F594BQ39309486-1A4A573F-79EA-4561-BD1F-3E6E98F8F236Q40287847-46B52914-A861-4596-A3A9-AFA0FC2AB00AQ40978843-C22CAB3A-9C59-4703-BE00-4FDEB25D52A3Q51748933-B1BB0F8C-A87B-4C8F-BE4C-F2899A6DD6FA
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A review of albumin binding in CKD.
@en
A review of albumin binding in CKD.
@nl
type
label
A review of albumin binding in CKD.
@en
A review of albumin binding in CKD.
@nl
prefLabel
A review of albumin binding in CKD.
@en
A review of albumin binding in CKD.
@nl
P1476
A review of albumin binding in CKD
@en
P2093
Kristin Verbeke
Pieter Evenepoel
P304
P356
10.1053/J.AJKD.2007.12.035
P577
2008-03-25T00:00:00Z